FORA Capital’s Sutro Biopharma STRO Stock Holding History

FORA Capital’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-81	Closed	-$18K	–	1137
2021 Q1	$18K	Sell	81 -177	-69%	-$42K	0.01%	705
2020 Q4	$56K	Buy	+258	New	+$42.7K	0.01%	761

Other funds holding STRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FORA Capital's STRO Position: Q2 2021 in Review

FORA Capital sold out of Sutro Biopharma (STRO) in Q2 2021, closing a stake of 81 shares — an estimated $18K sold.

FORA Capital first reported a position in STRO in Q4 2020 and held it in 2 quarters. The position peaked at $56K in Q4 2020. 124 funds tracked by Wall St. Rank hold STRO as of Q2 2021.

FORA Capital reported no remaining Sutro Biopharma position as of Q2 2021 after selling out during the quarter.
FORA Capital sold 81 Sutro Biopharma shares in Q2 2021, an estimated $18K.
FORA Capital first reported a position in Sutro Biopharma in Q4 2020 and held it in 2 quarters.
FORA Capital's Sutro Biopharma position peaked at $56K in Q4 2020.
124 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2021.

Based on FORA Capital's 13F filing for Q2 2021, filed 16 Aug 2021.